In pathological conditions, such as diabetes or hypertension, the concentration of ET-1 is increased because of the hyperglycaemia, acidosis and the presence of insulin, angiotensin II and proinflammatory cytokines, which causes sustained vasoconstriction. This evidence concerns the gene EDN1 and diabetes mellitus.